title: Changes in macular pigment optical density and serum concentrations of its constituent carotenoids following supplemental lutein and zeaxanthin: the LUNA study.
abstract: Macular pigment (MP), consisting of lutein (L) and zeaxanthin (Z), is believed to protect the retina from photo-oxidative damage. The current study investigates, in terms of MP optical density (MPOD) and serum concentrations of its constituent carotenoids, response to supplemental L and Z, and co-antioxidants. An intervention (I) group, consisting of 108 subjects (mean [+/-SD] age: 71.5 [+/-7.1] years), of which 92.6% exhibited features of age-related macular degeneration (AMD), received a daily supplement consisting of 12 mg L and 1 mg Z, both provided as ester 120 mg vitamin C, 17.6 mg vitamin E, 10 mg zinc, 40 microg selenium (Ocuvite Luteintrade mark) for a period of 6 months. MPOD was measured, by 2-wavelength autofluorescence (AF), on five occasions during the period of supplementation, and once again 3 months following discontinuation of the supplement. A control (C) group of 28 subjects (mean [+/-SD] age: 71.0 [+/-8.1] years), who received no dietary supplementation or modification, was examined at baseline and once again after a mean of 29.4 (+/-9.3) weeks. At baseline, mean (+/-SD) MPOD (at 0.5 degrees) was 0.504 (+/-0.197) and 0.525 (+/-0.189) in the I and C groups, respectively. There was a statistically significant increase in MPOD (at 0.5 degrees) for the I group (0.1 [+/-0.009]; p<0.0008), whereas no significant increase was seen in the C group (0.03 [+/-0.02]; p>0.05), over the period of supplementation. In order to classify supplemented subjects into quartiles, in terms of MPOD response, we calculated the difference between MPOD (at 0.5 degrees) at visit 6 and at baseline (visit 1). Quartile 1 (the "non-responder" quartile) displayed no increase in MPOD (at 0.5 degrees), in spite of rises seen in serum concentrations of L and Z. The three "responder" quartiles reached similar final plateaus of MPOD (at 0.5 degrees), reflected in final mean (+/-SEM) values of 0.59 (+/-0.04) optical density unit (ODU), 0.64 (+/-0.03) ODU and 0.64 (+/-0.03) ODU for quartiles 2, 3 and 4, respectively. Subjects with low baseline MPOD were more likely to exhibit a dramatic rise in MPOD, or to exhibit no rise in MPOD, in response to supplements than subjects with medium to high baseline MPOD values. Supplementation with 12 mg L and 1 mg Z, combined with co-antioxidants, resulted in an increase of MPOD at 0.5 degrees eccentricity in a majority of subjects, including those afflicted with AMD. However, there remains a substantial proportion of subjects for whom, in spite of rises in serum concentrations of L and Z in these subjects, MPOD augmentation in response to supplemental L, Z and co-antioxidants could not be detected over the study period, thus indicating that intestinal malabsorption of these carotenoids is not responsible for the lack of a macular response to such supplements. Further, our results suggest that saturable mechanisms play a role in the retinal capture and/or stabilisation of the macular carotenoids.
authors.affiliation: Institute of Ophthalmology, St. Franziskus Hospital, and Institute of Epidemiology, University of Münster, Germany. meiketri@aol.com
authors.forename: Meike
authors.initials: M
authors.lastname: Trieschmann
authors.forename: Stephen
authors.initials: S
authors.lastname: Beatty
authors.forename: John M
authors.initials: JM
authors.lastname: Nolan
authors.forename: Hans Werner
authors.initials: HW
authors.lastname: Hense
authors.forename: Britta
authors.initials: B
authors.lastname: Heimes
authors.forename: Ulrike
authors.initials: U
authors.lastname: Austermann
authors.forename: Manfred
authors.initials: M
authors.lastname: Fobker
authors.forename: Daniel
authors.initials: D
authors.lastname: Pauleikhoff
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000975:Antioxidants / Q000008:administration & dosage; D019587:Dietary Supplements; D005260:Female; D006801:Humans; D008075:Lipoproteins, HDL / Q000097:blood; D014975:Lutein / Q000008:administration & dosage* / Q000097:blood; D008266:Macula Lutea / Q000378:metabolism; D008268:Macular Degeneration / Q000097:blood / Q000378:metabolism*; D008297:Male; D008875:Middle Aged; D024341:Xanthophylls / Q000008:administration & dosage* / Q000097:blood; D065146:Zeaxanthins
chemical_list: D000975:Antioxidants; D008075:Lipoproteins, HDL; D024341:Xanthophylls; D065146:Zeaxanthins; D014975:Lutein